These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22771891)

  • 21. Hydroxyproline metabolism in mouse models of primary hyperoxaluria.
    Knight J; Holmes RP; Cramer SD; Takayama T; Salido E
    Am J Physiol Renal Physiol; 2012 Mar; 302(6):F688-93. PubMed ID: 22189945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The enzyme 4-hydroxy-2-oxoglutarate aldolase is deficient in primary hyperoxaluria type 3.
    Williams EL; Bockenhauer D; van't Hoff WG; Johri N; Laing C; Sinha MD; Unwin R; Viljoen A; Rumsby G
    Nephrol Dial Transplant; 2012 Aug; 27(8):3191-5. PubMed ID: 22391140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tritium exchange reactions catalyzed by 2-oxo-4-hydroxyglutarate aldolase from Escherichia coli K-12.
    Grady SR; Dekker EE
    Biochim Biophys Acta; 1979 May; 568(1):234-42. PubMed ID: 375986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasis.
    Monico CG; Rossetti S; Belostotsky R; Cogal AG; Herges RM; Seide BM; Olson JB; Bergstrahl EJ; Williams HJ; Haley WE; Frishberg Y; Milliner DS
    Clin J Am Soc Nephrol; 2011 Sep; 6(9):2289-95. PubMed ID: 21896830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydroxyproline metabolism in a mouse model of Primary Hyperoxaluria Type 3.
    Li X; Knight J; Todd Lowther W; Holmes RP
    Biochim Biophys Acta; 2015 Dec; 1852(12):2700-5. PubMed ID: 26428388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular aetiology of primary hyperoxaluria and its implications for clinical management.
    Danpure CJ; Rumsby G
    Expert Rev Mol Med; 2004 Jan; 6(1):1-16. PubMed ID: 14987413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigations into the effect of glyoxylate decarboxylation and transamination on oxalate formation in the rat.
    Bais R; Rofe AM; Conyers RA
    Nephron; 1991; 57(4):460-9. PubMed ID: 2046830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical characterization of primary hyperoxaluria type 3 in comparison with types 1 and 2.
    Singh P; Viehman JK; Mehta RA; Cogal AG; Hasadsri L; Oglesbee D; Olson JB; Seide BM; Sas DJ; Harris PC; Lieske JC; Milliner DS
    Nephrol Dial Transplant; 2022 Apr; 37(5):869-875. PubMed ID: 33543760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gly161 mutations associated with Primary Hyperoxaluria Type I induce the cytosolic aggregation and the intracellular degradation of the apo-form of alanine:glyoxylate aminotransferase.
    Oppici E; Roncador A; Montioli R; Bianconi S; Cellini B
    Biochim Biophys Acta; 2013 Dec; 1832(12):2277-88. PubMed ID: 24055001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe child form of primary hyperoxaluria type 2 - a case report revealing consequence of GRHPR deficiency on metabolism.
    Konkoľová J; Chandoga J; Kováčik J; Repiský M; Kramarová V; Paučinová I; Böhmer D
    BMC Med Genet; 2017 May; 18(1):59. PubMed ID: 28569194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HOGA1 Gene Mutations of Primary Hyperoxaluria Type 3 in Tunisian Patients.
    M'dimegh S; Aquaviva-Bourdain C; Omezzine A; Souche G; M'barek I; Abidi K; Gargah T; Abroug S; Bouslama A
    J Clin Lab Anal; 2017 May; 31(3):. PubMed ID: 27561601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reconstruction of human hepatocyte glyoxylate metabolic pathways in stably transformed Chinese-hamster ovary cells.
    Behnam JT; Williams EL; Brink S; Rumsby G; Danpure CJ
    Biochem J; 2006 Mar; 394(Pt 2):409-16. PubMed ID: 16309382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous analysis of urinary metabolites for preliminary identification of primary hyperoxaluria.
    Clifford-Mobley O; Hewitt L; Rumsby G
    Ann Clin Biochem; 2016 Jul; 53(Pt 4):485-94. PubMed ID: 26342005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glyoxylate reductase activity in blood mononuclear cells and the diagnosis of primary hyperoxaluria type 2.
    Knight J; Holmes RP; Milliner DS; Monico CG; Cramer SD
    Nephrol Dial Transplant; 2006 Aug; 21(8):2292-5. PubMed ID: 16597637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The gene encoding hydroxypyruvate reductase (GRHPR) is mutated in patients with primary hyperoxaluria type II.
    Cramer SD; Ferree PM; Lin K; Milliner DS; Holmes RP
    Hum Mol Genet; 1999 Oct; 8(11):2063-9. PubMed ID: 10484776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary hyperoxaluria type 2: enzymology.
    Giafi CF; Rumsby G
    J Nephrol; 1998; 11 Suppl 1():29-31. PubMed ID: 9604806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary hyperoxalurias: disorders of glyoxylate detoxification.
    Salido E; Pey AL; Rodriguez R; Lorenzo V
    Biochim Biophys Acta; 2012 Sep; 1822(9):1453-64. PubMed ID: 22446032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ATP-dependent degradation of a mutant serine: pyruvate/alanine:glyoxylate aminotransferase in a primary hyperoxaluria type 1 case.
    Nishiyama K; Funai T; Yokota S; Ichiyama A
    J Cell Biol; 1993 Dec; 123(5):1237-48. PubMed ID: 8245128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic basis of primary hyperoxaluria type II.
    Webster KE; Cramer SD
    Mol Urol; 2000; 4(4):355-64. PubMed ID: 11156703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glyoxylate reductase: Definitive identification in human liver mitochondria, its importance for the compartment-specific detoxification of glyoxylate.
    Garrelfs SF; Chornyi S; Te Brinke H; Ruiter J; Groothoff J; Wanders RJA
    J Inherit Metab Dis; 2024 Mar; 47(2):280-288. PubMed ID: 38200664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.